Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth

about

The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

P2860

Q39029195-1E66957A-953E-4A50-8E0F-4AB36EEDAD4D Q58765200-83D52AC4-11A0-467A-AE1F-D6908A6618CB

P2860

Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth

Item

http://www.wikidata.org/entity/Q36445743

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Synergistic suppression of the ...... on mantle cell lymphoma growth

@ast

Synergistic suppression of the ...... on mantle cell lymphoma growth

@en

type

Item

label

Synergistic suppression of the ...... on mantle cell lymphoma growth

@ast

Synergistic suppression of the ...... on mantle cell lymphoma growth

@en

prefLabel

Synergistic suppression of the ...... on mantle cell lymphoma growth

@ast

Synergistic suppression of the ...... on mantle cell lymphoma growth

@en

P1476

Synergistic suppression of the ...... on mantle cell lymphoma growth

@en

P2093

Bing Xia

http://www.w3.org/2001/XMLSchema#string

Chen Tian

http://www.w3.org/2001/XMLSchema#string

Fu-Lian Qu

http://www.w3.org/2001/XMLSchema#string

Hong-Liang Yang

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Su-Xia Li

http://www.w3.org/2001/XMLSchema#string

Ya-Fei Wang

http://www.w3.org/2001/XMLSchema#string

Yi-Zhuo Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.

PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

Novel targeted therapies for mantle cell lymphoma

Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma.

P304

401-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7497/J.ISSN.2095-3941.2015.0013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26779377

http://www.w3.org/2001/XMLSchema#string

P932

4706520

http://www.w3.org/2001/XMLSchema#string

Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth

about

P2860

P2860

Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932